Compugen Shares Dip 14.86% Amid Modest Market Decline, Trading at $1.93
Compugen’s share price fell 14.9% to $1.93, trailing the market with a $202 M cap while still focusing on genomics‑based cancer therapies.
2 minutes to read
COMPUGEN LTD
Compugen (CGEN) Gains 0.51% but Faces Deep Red: What Investors Need to Know
Compugen shares dip 19% since February, barely moving up while peers surge—investors weigh genomics hype against weak market traction.
3 minutes to read